Trial intelligence / Profile preview

Mycophenolate mofetil vs cyclophosphamide for remission induction in ANCA-associated vasculitis

2006-001663-33Phase 2Completed

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mycophenolate mofetil in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Oct 2006; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)

Beyond the preview

Go deeper on 2006-001663-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001663-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call